Technology: Orbexa®
Eurand’s Orbexa technology produces beads of a controlled size and density using granulation spheronization, and extrusion techniques. These beads provide high drug concentrations and can be coated with functional polymer membranes for additional release rate control.
Orbexa beads can be filled into capsules or single-dose sachets.
Advantages of Orbexa
- Aqueous or solvent-based granulation
- High-speed process is well suited for sensitive molecules like proteins
- Suitable for high drug loading
More Information
For more information, contact Eurand at partners@eurand.com or +1-267-759-9340
contact Eurand +